Mode
Text Size
Log in / Sign up
Phase 4 Completed N=350 Randomized Single-blind Treatment

Deep Neuromuscular Block for Laparoscopic Surgery

Laparoscopy · Anesthesia Recovery Period
Source: ClinicalTrials.gov NCT03034577 ↗
Enrolled (actual)
350
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcomePrimary: Percentage of Patients Recovered Cognitively at 1 Week — 91.8; 92.9 percentage of patients recovered
◆ Published Evidence
Established
25citations · ~4 / year
A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine.
Anaesthesia · 2020 · Open access · Likely link

Summary

Trial summary: deep neuromuscular block is proposed as a technique to improve operative conditions for laparoscopy. Early clinical data would suggest that there may also be patient benefits beyond the operative period related to lower intra-abdominal pressure, and improved surgical exposure. In order to safely conduct deep neuromuscular blockade, it is essential to use Sugammadex to reverse the neuromuscular block. Conventional practice is to provide moderate neuromuscular block and reverse with neostigmine. It is not possible to safely reverse deep neuromuscular block using neostogmine, as the majority of block must have worn off for neostigmine to be effective. in order to identify whether deep neuromuscular block improves quality of recovery after surgery, the investigators will conduct a randomised trial of deep versus moderate neuromuscular block, whilst minimising variance in other anaesthetic techniques and drugs used. the outcome measured will be the post-operative quality of recovery over multiple time periods using the Postoperative Quality of Recovery Scale (PostopQRS). 350 patients will be enrolled over 4 centres.

Linked Publications

  • A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine.
    Anaesthesia · 2020 · 25 citations · Open access · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Patients Recovered Cognitively at 1 Week
91.8; 92.9
SECONDARY
Percentage of Patients Recovered in All Domains of the Postoperative Quality of Recovery Scale at 3 Months After the Operation
75.7; 73
SECONDARY
Number of Participants With Full Reversal of Neuromuscular Blockade Prior to Extubation
158; 161
SECONDARY
Duration of Anesthesia From Induction to Cessation of the Anesthetic
165.4; 164
SECONDARY
Number of Participants Categorized by Level of Surgical Satisfaction
104; 94; 38; 48; 20; 16
SECONDARY
Duration of Hospital Length of Stay
2.6; 1.8

Eligibility Criteria

Inclusion Criteria

  • Adult participants
  • operative gynecological or abdominal surgery
  • receiving general anesthesia
  • Operation expected to exceed1 hour duration
  • Participants must speak sufficient English to answer the survey questions

Exclusion Criteria

  • Participants undergoing diagnostic laparoscopy only
  • Participants <18 years of age
  • Current pregnancy
  • Known allergy to rocuronium, neostigmine or sugammadex, or desflurane
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03034577) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search